FDA clears Heartflow’s next-gen plaque analysis
Article Title: FDA Clears Heartflow’s Next-Gen Plaque Analysis Date: Tue, 23 Sep 2025 As reported by BioWorld, Heartflow Inc., a front-runner in advancing heart health technology, has obtained U.S. FDA 510(k) clearance for its latest plaque analysis algorithm and platform.…